The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.
申请公布号
WO0197805(A3)
申请公布日期
2002.08.29
申请号
WO2001EP06983
申请日期
2001.06.20
申请人
NOVARTIS AG;NOVARTIS-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H;GANTER, SABINA, MARIA;WAGNER, ROBERT, FRANK